MedPage Today on MSN
How Patients Feel About AI-Drafted Portal Messages
Broad consensus about need for disclosure and clinician oversight ...
Vor Biopharma pivots to telitacicept for autoimmune diseases, backed by $491M cash to 2029. Click here to read an analysis of ...
We're grading the biggest free agent signings and extensions, including the Cavaliers signing Mitchell to a nearly $275 ...
These large energy-consuming projects are reshaping communities across America. What's their real impact? Here's our ...
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, ...
(AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF) ("Pulsar" or the "Company"), a primary helium company, is pleased to announce the results of its Fundraise, as announced yesterday. Due to strong investor demand, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results